chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness of face, tongue, throat; Tingling of face, tongue, throat; A spontaneous report was received from a health care professional concerning a 60-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced numbness and tingling of face, tongue and throat.  The patient's medical history was Rheumatoid arthritis, hypertension and possible allergy to diphenhydramine and meperidine. No relevant concomitant medications were reported.   On 13 Jan 2021 at 10:11 A.M., prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 13 Jan 2021 at 10:15 A.M., after receiving the vaccine, patient started to experience numbness and tingling of face, tongue and throat.  Initial examination included lungs angiogram, which indicated regular tachycardia. Findings included swelling of lips and tongue, and uvula midplane, not deviated. The patient was moved on an observation area. Emergency medical services (EMS) were notified. Intramuscular (IM) epinephrine was administered at 10:23 A.M. At 10:25 A.M. the patient's vital signs included blood pressure 185/87, heart rate 128, respiratory rate 20, and oxygen saturation 100%. A second IM epinephrine treatment was given at 10:26 A.M. At 10:29 A.M. the patient's vital signs included blood pressure 185.87, heart rate 134, and oxygen saturation 100%. At 10:29 A.M. treatment included oral diphenhydramine. Next dose of IM epinephrine failed; a fourth dose was given at 10:35 A.M. At 10:45 A.M., EMS arrived, and the patient was taken to the emergency room.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The outcome for the events, numbness and tingling of face, tongue and throat was unknown.; Reporter's Comments: This case concerns a 60 year-old, female patient, who experienced events of numbness and tingling of face, tongue and throat. The events occurred within minutes after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.
0945 Patient reports tingling tongue; itching on upper arms; facial flushing HR 83; SPO2 99%; BP 150/100 - patient states she did not take BP meds today   0957 Patient administered 50mg Benadryl PO  1030 Patient released; reports symptoms remained mild and felt  stable enough to return home
This initial spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant mediation or drug allergies/drug reactions described. On 11-SEP-2015, the patient was vaccinated with a dose of an improperly stored (Merck) VARIVAX injection (lot # L009203 with expiration date 17-MAR-2017; strength, dose and route were not provided). Product quality complaint (PQC) was not involved. No adverse effects were reported. Additional information has been requested.
I got the ZOSTAVAX vaccine and had a bad reaction. The second day I got a large lump at the site which is normal but on the third day I broke out in a terribly itchy red rash all over my chest and neck. I felt feverish. It continued getting worse the fourth, fifth, and sixth days. I took BENADRYL and used cortisone cream which didn't help very much. Today is the seventh day and it has spread to my legs and arms but is less itchy. I hope it won't leave scarring or discoloring when it passes.
pt presented to hospital with viral sepsis, encephalopathy, positive COVID test, hypoxia due to COVID; failure to thrive (wt loss of 100# in past year with poor appetite; ABX; Remdesivir; Dexamethasone; O2 supplementation intermittently; pt had a cardiac arrest and passed away in the hospital
On April 8/2022 I got my second booster. On the 04/20/2022 started experiencing the adverse event at around 8:00PM I had stuffy nose. The next day I took Mucinex for 3-4 days. A lot of nasal discharge. On Thursday of April 21 I tested negative. On Saturday 23rd I tested positive for COVID. I called my doctor he told me to wear mask and stay home for five days. I was fine the next day. Even thought I had all of my vaccines and boosters I contacted COVID.
This is a prospective pregnancy case. This 39-year-old female subject was enrolled in a study. The subject received BOOSTRIX (intramuscular) .5 ml on 19th August 2014. The subject received BOOSTRIX during the third trimester of pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. Additional information: The last menstrual period, the due date and the number of gestational weeks were not reported. This is one of the 17 cases reported by the same reporter for the same vaccine.
After 7 days my injection site became "itchy", then bright red, mild swelling and very warm to the touch.  Worsening after 24 hrs.
Vaginal bleeding-brown blood-almost as much as in normal period, however pt has periods recurring every 28 days and last period started 12/10/99.
Received first vaccine on Thurs, Feb 4. Had a bruise at injection site that appeared later in the day. Applied arnica gel daily, with no results. Woke up morning of Tues, Feb 9 with soreness below injection site with redness and inflammation. On Wed, Feb 10, the area was larger and began itching. Have not noticed rash-like bumps, but the skin in the area is warmer to the touch than the rest of the arm
Client complains of having diarrhea for 1-2 day after receiving Rabies vaccines. Client received Rabies vaccine #1 on 10-01-18 at Health District. Client received Rabies vaccine #2 on 10-05-18, Rabies vaccine #3 on 10-10-18 and Rabies vaccine #4 on 10-17-18. Dose 2, 3 and 4 were given at HD. Client was referred to PCP for evaluation. Client did complete indicated Rabies vaccine treatment.
Exhaustion, depression, loss of appetite, soreness and tightening of throat on the third day after injection.  Severe moodiness, short temper, loss of interest in everything.  When lying down to sleep a strong, tingling , electrifying sensation that started at my left foot moving up to my groin area.
swelling/ redness/ blistering to left arm We gave patient Benadryl by mouth in our office.
BLURRED VISION EXPERIENCED TWO TIMES MORE; VISUAL DISTURBANCE, AT DISTANCE OF 10 FEET AND MORE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 20-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced blurred vision experienced two times more, and visual disturbance, at distance of 10 feet and more. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blurred vision experienced two times more, and visual disturbance, at distance of 10 feet and more. This report was non-serious.
Severe pain starting in left forearm extending down to the hand and tingling/numbness in hand. Pain started to travel up the arm towards the bicep.
This case was reported by a consumer and described the occurrence of body hives in a 60-year-old female subject who was vaccinated with Influenza vaccine (unspecified manufacturer). A physician or other health care professional has not verified this report. In 2004, the subject received unspecified dose of Influenza vaccine (unspecified) (unknown route, unknown arm and batch number). In 2004, 6 to 8 hours after vaccination with Influenza vaccine (unspecified), the subject experienced body hives, face swollen, shortness of breath, lung inflammation. The subject was treated with BENADRYL, CORITSOL and prednisone. The events were resolved and lasted a couple of days. She was told at that time to not get the Flu vaccine again but she got the flu one year and it was bad. She received 2 separate half doses of Flu vaccine for the last 2 years. She received a half of dose and then went back in about a week and received another half dose. Prior to this, she got the Flu vaccine in 4 injections every half hour. She stated her doctors have titrated her Flu dose in the past and this works well for her.
Pt had sudden onset of nausea and light headedness about 5-10 minutes after injection. Pt States that He had a history of vasovagal reactions. No LOC occurred. No vomitting. Pt was monmitored for 15 mintues with complete resolution of symptoms
Medical Assistant states pt. started bleeding immediately after she administered The vaccine. MA states that as she was wiping The blood from the pts. arm she noticed hematoma. MA notified provider. 67 Years Male here for f/u. pt has cardio eval and was told everything was normal (no report). pt endorses occasional dizziness with standing and on hot days working out doors. h/o dizziness last 2 mins. occur from sitting to standings. h/o fatigue. h/o hypothyroidism has fatigue denies heat/cold intolerance HTN - Denies headache chest pain leg swelling.
intermittent headache; vertigo; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number unknown), via unspecified route of administration on 20Mar2021 as single dose for COVID-19 immunization. No medical history was reported. The concomitant medications were not reported. Since the vaccination, patient experienced intermittent headache and vertigo on an unspecified date. The reporter assessed the events as non-serious. The outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Cough; No energy; Did not feel good; Sick to her stomach; Cold like symptoms; Rash on neck that she can still feel; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 11-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach) and NASOPHARYNGITIS (Cold like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea). At the time of the report, COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea) was resolving.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-119331 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021contains no new information. On 11-Jun-2021: Follow-up information received on 11-Jun-2021 contains updated event outcome.
Pt recvd 3 doses of Engerix-B on 17MAY90, 20JUN90, & 28NOV90 & was found to be a non-responder;
This spontaneous report was received from a female patient of unknown age reporting in herself. Information about concurrent conditions and medical history was not provided. On an unknown date the patient was scheduled to receive ZOSTAVAX but patient was accidentally given with VARIVAX (Merck) (route, dose, lot, batch and expiration date not reported) and developed chickenpox on her face which lasted for a week. A week after receiving VARIVAX (Merck) the patient received ZOSTAVAX. No adverse effects were reported after ZOSTAVAX . Patient spoke with pharmacist about the event. Additional information is not expected because the patient did not wish to provide specific information.
Allergic reaction to covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic reaction to covid vaccine) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) solution for injection for Plaque psoriasis.    Concomitant products included LYSINE, ZINC, VITAMIN B12 [VITAMIN B12 NOS], CALCIUM, VITAMIN D [VITAMIN D NOS], CINNAMOMUM CASSIA (CINNAMON [CINNAMOMUM CASSIA]), CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), MELATONIN, DULOXETINE HYDROCHLORIDE (CYMBALTA), GABAPENTIN, DULOXETINE HCL, GABAPENTIN and MAGNESIUM for an unknown indication.   In April 2020, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 75 milligram twice a day. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic reaction to covid vaccine). At the time of the report, ALLERGY TO VACCINE (Allergic reaction to covid vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment information was provided by the reporter. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
This spontaneous report was received from a physician, via a company representative, referring to a 13 year old female patient. The patient's medical history included; a past drug reaction with ZITHROMAX. No information was provided regarding the patient's concurrent conditions and concomitant medications. The patient had none laboratories performed. In 2017, (reported as about a year ago) the patient was vaccinated with GARDASIL 9, 0.5 ml, intramuscular, scheduled at: (0, 2 months and 6 months) for prevention of human papilloma virus infection (HPV), (strength, lot number and expiration date were not reported). Subsequently the patient required medical attention because she broke out in a rash across her entire body. The rash consisted of red, raised bumps and was itchy (rash erythematous, rash papular and rash pruritic) however the rash went away after 3 weeks. The outcome of rash generalised, rash pruritic, rash papular and rash erythematous was reported as resolved, on unspecified date in 2017. At the time of the report, the casual relationship between the aforementioned events and GARDASIL 9 was not reported.
sore. then at 1am felt Like truck hit her. cant move too much. Took Tylenol 1030am and took 1g for 102.7 this morning. fatigue. Narrative:  feeling sore today, after taking second dose of Moderna vaccine yesterday, then at 0100 am overnight she felt Like truck hit her. can't move too much due to body ache and fatigue. Took 1g Tylenol Last at 10:30am this morning.
Information has been received from a certified medical assistant concerning a patient who on 14-AUG-2008 was vaccinated orally with a second 2ml dose of ROTATEQ vaccine live (human-bovine) 11 weeks after first dose. The first dose of ROTATEQ vaccine live (human-bovine) was given on 28-MAY-2008. There were no adverse effects reported. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Incident: RN discovered client pale, clammy and slumping in chair and complaining of being dizzy, lightheaded and nauseous.  Pt transferred by w/c to recovery site to rest on cot.  1607 supine BP 100/60 HR 60 provided with juice.  Pts resting and conversing with staff color is improving but complaining of chills at this time and covered with jacket.  1612 BP 100/60 HR 60 O2 sat100%.  Pt states that the vertigo is improving and denies nausea.  Explained to client the vasovagal response and why she has experienced these post vaccination symptoms  1620 Pt dangling on the side of cot sitting BP 100/60 PR 57 O2 sat 99% .   Pt c/o vertigo and moved back to supine position and encouraged to rest and sip juice.  Reassured that this is a recovery process and will try again in after some time has passed.  1629 Pt dangling on the side of cot without vertigo or lightheadedness continue to have chills and sipping apple juice.  Pt walked to post vaccination area with staff and friend to remain for post observation.  Pt denies that she has not had this experience before with any vaccine.  Informed patient that this is an involuntary response and to share this with the RN at next appointment.  Provided the patient with the option that for second dose that she can be vaccinated supine and eat and drink before appointment.   1645 Pt. made a full recovery and escorted out of the clinic with friend.
10/7/11 9:30A she received FLUZONE HIGH DOSE at Flu shot clinic - she came & ask to see us at 1:55 PM describing tightness in her throat that had gradually increasing - onset 11 AM - she also had c/o sinus drainage & cough - we called EMS & she was transferred to Emergency room - Dx was mild to moderate reaction to Flu vaccine. Tx with BENADRYL and prednisone.
24 hours after receiving vaccination in left arm, left elbow is swollen to about the size of a golf ball and appears to be filled with fluid. He is deaf and has difficulty communicating but did say there was some pain involved the inflamed area of the elbow.
had extreme fatigue; Itchy rash on hands and forearm; Itchy rash on hands and forearm. More on the left side where he received the vaccine; Itchy rash on hands and forearm. More on the left side where he received the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received the first dose of bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 18Jan2021 at single dose in left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 18Jan2021 was first dose of covid vaccine, 2 days later (20Jan2021) he had extreme fatigue, itchy rash on hands and forearm. More on the left side where he received the vaccine. Wondering if this was a normal reaction to the vaccine.  The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Left thumb and all the way to the wrist sore, inflammation, very painful, sore, tender, stiff. on a scale of 1 to 10 on pain, it is an 8.  Keep thinking it will get better each day but it is not getting better.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 09-JUL-2015, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) lot # L000454, expiry date 06-JAN-2017 (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Miscarriage at 9 weeks gestation - no heartbeat on ultrasound.  This was 2 months after my Moderna Covid-19 booster shot.  I am 39 years old - the vaccine is probably unrelated but wanted to report so that you have the data.
This spontaneous report was received from a registered pharmacist refers to an approximately 54-year-old female patient. On 25-APR-2013 the patient was vaccinated with 0.65 milliliter (ml) ZOSTAVAX (lot# J000493, expiration date 14-APR-2014), subcutaneously. Approximately on an unknown date in April 2013, the patient experienced swollen ankles. The outcome of swollen ankles was reported as not recovered/not resolved. Patient did not seek medical attention for the event. It was unspecified whether lab diagnostic studies were performed. Causality was not reported. Additional information has been requested.
Fever (99.9, my base temp is 97.9), chills, body aches
2nd dose 16Feb2023, 1st a month ago/ 1 month after 1st dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number FG7RF, expiry date 21st April 2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 16th February 2023, the patient received the 2nd dose of Shingrix. On 16th February 2023, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt date: 16-Feb-2023. Reporter's Comment: The pharmacist reported that the 2nd dose of Shingrix was given only 1 month after the 1st dose to a patient. The reporter consent to follow-up. Additional Supportive Information: Patient received 2nd dose early than the recommended schedule, which led to shortening of vaccination schedule.
When I got the vaccine, I had almost passed out and felt like I needed to vomit. Later, I started getting really cold and shivering, and there was nothing I could do to make it stop. I started getting a headache, nausea, and weakness around that time too, maybe a bit sooner, like 3:00pm. The chills  started at around 5:00pm.
Information has been received from a nurse concerning an 82 year old female patient who on 14-OCT-2010 was vaccinated with a dose of PNEUMOVAX 23 (Lot # 667914/1067Z, expire date February 2012, route not reported), 0.5 ml, in her right arm. Concomitant therapy included FLUZONE, in her left arm, administered on the same day, aspiring, PREVACID, metoprolol and CARDIZEM. Nurse stated that on 27-OCT-2010, the patient notified the doctor that she was having pain in her right arm. The doctor recommended that she took ALEVE and VICODIN. On 05-NOV-2010, the patient had a sonogram and a magnetic resonance imaging (MRI) on her right shoulder and an X-ray of her right arm on 08-DEC-2010 (results not provided). The patient was prescribed gabapentin for the pain. The patient came to the doctor's office in February 2011 for a neurological disorder. At the time of the report, patient's outcome was unknown. This is one of two reports received from the same source. Additional information has been requested.
With first shot just body aches; This is a spontaneous report from a contactable nurse (patient). A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899), intramuscular in right arm on 17Dec2020 at a single dose for covid-19 immunization. Medical history included depression. Patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. The patient experienced with first shot just body aches on an unspecified date. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered.